Skip to main content
Erschienen in: Japanese Journal of Ophthalmology 4/2020

21.04.2020 | Forefront Review

Pachychoroid disease: a new perspective on exudative maculopathy

verfasst von: Yasuo Yanagi

Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Pachychoroid, or the structural and functional abnormalities of the choroid, is one of the most important causes of exudative maculopathies. The purpose of this article is to review the current definitions of pachychoroid and their potential consequences.

Summary of findings

Most publications are from Asian countries. Although no consensus diagnosis has been reached, pachychoroid is defined by thickened choroid and choroidal vascular hyperpermeability, pachyvessels with inner choroidal attenuation; it is closely linked to pachydrusen. Although some studies suggest choroidal congestion may play a role in its pathogenesis, the exact causes of this condition are still unknown. Pachychoroid is associated with exudative maculopathies including central serous chorioretinopathy, pachychoroid neovasculopathy and polypoidal choroidal vasculopathy (PCV). It is widely accepted that macular neovascular membranes may develop secondary to pachychoroid. Recent clinical observations illustrate the importance of pachychoroid in the etiology of macular neovascularization including neovascular age-related macular degeneration (nAMD).

Conclusion

Pachychoroid is an important cause of exudative maculopathies. Both drusen and pachychoroid are increasingly recognized as important causes of macular neovascularization, and eyes formally categorized as typical nAMD or PCV can be further sub-categorized based on the presence or absence of pachychoroid and drusen. There is a need to develop a consensus definition, which will greatly enhance our understanding of pachychoroid and facilitate the development of individual interventions in pachychoroid diseases.
Literatur
1.
Zurück zum Zitat Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996;16:203–13.PubMed Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996;16:203–13.PubMed
2.
Zurück zum Zitat Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol. 1986;9:37–41.PubMed Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol. 1986;9:37–41.PubMed
3.
Zurück zum Zitat Guyer DR. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057.PubMed Guyer DR. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol. 1994;112:1057.PubMed
4.
Zurück zum Zitat Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol. 2006;142:601–7.e1. Sasahara M, Tsujikawa A, Musashi K, Gotoh N, Otani A, Mandai M, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol. 2006;142:601–7.e1.
5.
Zurück zum Zitat Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811–5.PubMed Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811–5.PubMed
6.
Zurück zum Zitat Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.PubMed Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.PubMed
7.
Zurück zum Zitat Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469–73.PubMed Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29:1469–73.PubMed
8.
Zurück zum Zitat Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, et al. Choroidal thickness, vascular hyperpermeability, and complement factor h in age-related macular degeneration and polypoidal choroidal vasculopathy. Investig Opthalmol Vis Sci. 2012;53:3663. Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, et al. Choroidal thickness, vascular hyperpermeability, and complement factor h in age-related macular degeneration and polypoidal choroidal vasculopathy. Investig Opthalmol Vis Sci. 2012;53:3663.
9.
Zurück zum Zitat Koizumi H, Yamagishi T, Yamazaki T, Kinoshita S. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol. 2013;155:305–13.e1. Koizumi H, Yamagishi T, Yamazaki T, Kinoshita S. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability. Am J Ophthalmol. 2013;155:305–13.e1.
10.
Zurück zum Zitat Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33:1659–72.PubMed Warrow DJ, Hoang QV, Freund KB. Pachychoroid pigment epitheliopathy. Retina. 2013;33:1659–72.PubMed
11.
Zurück zum Zitat Siedlecki J, Schworm B, Priglinger SG. The pachychoroid disease spectrum—and the need for a uniform classification system. Ophthalmol Retina. 2019;3:1013–5.PubMed Siedlecki J, Schworm B, Priglinger SG. The pachychoroid disease spectrum—and the need for a uniform classification system. Ophthalmol Retina. 2019;3:1013–5.PubMed
12.
Zurück zum Zitat Iida T, Hagimura N, Takahashi K, Muraoka K. Study of choroidal vascular lesions in bullous retinal detachment by indocyanine green angiography. J Jpn Ophthalmol Soc. 1995;99:945–54 (in Japanese). Iida T, Hagimura N, Takahashi K, Muraoka K. Study of choroidal vascular lesions in bullous retinal detachment by indocyanine green angiography. J Jpn Ophthalmol Soc. 1995;99:945–54 (in Japanese).
13.
Zurück zum Zitat Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R, Chan CM, et al. Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina. 2018;38:1509–17.PubMed Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R, Chan CM, et al. Choroidal vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina. 2018;38:1509–17.PubMed
14.
Zurück zum Zitat Miyake M, Tsujikawa A, Yamashiro K, Ooto S, Oishi A, Tamura H, et al. Choroidal neovascularization in eyes with choroidal vascular hyperpermeability. Investig Opthalmology Vis Sci. 2014;55:3223. Miyake M, Tsujikawa A, Yamashiro K, Ooto S, Oishi A, Tamura H, et al. Choroidal neovascularization in eyes with choroidal vascular hyperpermeability. Investig Opthalmology Vis Sci. 2014;55:3223.
15.
Zurück zum Zitat Fung AT, Yannuzzi LA, Freund K. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32:1829–37.PubMed Fung AT, Yannuzzi LA, Freund K. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32:1829–37.PubMed
16.
Zurück zum Zitat Nomura Y, Takahashi H, Tan X, Obata R, Yanagi Y. Widespread choroidal thickening and abnormal midperipheral fundus autofluorescence characterize exudative age-related macular degeneration with choroidal vascular hyperpermeability. Clin Ophthalmol. 2015;9:297–304.PubMedPubMedCentral Nomura Y, Takahashi H, Tan X, Obata R, Yanagi Y. Widespread choroidal thickening and abnormal midperipheral fundus autofluorescence characterize exudative age-related macular degeneration with choroidal vascular hyperpermeability. Clin Ophthalmol. 2015;9:297–304.PubMedPubMedCentral
17.
Zurück zum Zitat Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35:1–9.PubMed Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35:1–9.PubMed
19.
Zurück zum Zitat Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204.PubMedPubMedCentral Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204.PubMedPubMedCentral
20.
Zurück zum Zitat Nakayama M, Keino H, Okada AA, Watanabe T, Taki W, Inoue M, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt–Koyanagi–Harada disease. Retina. 2012;32:2061–9.PubMed Nakayama M, Keino H, Okada AA, Watanabe T, Taki W, Inoue M, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt–Koyanagi–Harada disease. Retina. 2012;32:2061–9.PubMed
21.
Zurück zum Zitat Spaide RF, Goldbaum M, Wong DWK, Tang KC, Iida T. Serous detachment of the retina. Retina. 2003;23:820–46.PubMed Spaide RF, Goldbaum M, Wong DWK, Tang KC, Iida T. Serous detachment of the retina. Retina. 2003;23:820–46.PubMed
22.
Zurück zum Zitat Lee M, Lee H, Kim HC, Chung H. Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases. Investig Ophthalmol Vis Sci. 2018;59:4896–908. Lee M, Lee H, Kim HC, Chung H. Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases. Investig Ophthalmol Vis Sci. 2018;59:4896–908.
23.
Zurück zum Zitat Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina. 2016;36:499–516.PubMed Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina. 2016;36:499–516.PubMed
24.
Zurück zum Zitat Baek J, Lee JH, Jung BJ, Kook L, Lee WK. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:2309–17. Baek J, Lee JH, Jung BJ, Kook L, Lee WK. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:2309–17.
25.
Zurück zum Zitat Hiroe T, Kishi S. Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retina. 2018;2:152–61.PubMed Hiroe T, Kishi S. Dilatation of asymmetric vortex vein in central serous chorioretinopathy. Ophthalmol Retina. 2018;2:152–61.PubMed
26.
Zurück zum Zitat Matsumoto H, Kishi S, Mukai R, Akiyama H. Remodeling of macular vortex veins in pachychoroid neovasculopathy. Sci Rep. 2019;9:14689.PubMedPubMedCentral Matsumoto H, Kishi S, Mukai R, Akiyama H. Remodeling of macular vortex veins in pachychoroid neovasculopathy. Sci Rep. 2019;9:14689.PubMedPubMedCentral
27.
Zurück zum Zitat Mori K. Asymmetry of choroidal venous vascular patterns in the human eye. Ophthalmology. 2004;111:507–12.PubMed Mori K. Asymmetry of choroidal venous vascular patterns in the human eye. Ophthalmology. 2004;111:507–12.PubMed
28.
Zurück zum Zitat Daizumoto E, Mitamura Y, Sano H, Akaiwa K, Niki M, Yamanaka C, et al. Changes of choroidal structure after intravitreal aflibercept therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2017;101:56–61.PubMed Daizumoto E, Mitamura Y, Sano H, Akaiwa K, Niki M, Yamanaka C, et al. Changes of choroidal structure after intravitreal aflibercept therapy for polypoidal choroidal vasculopathy. Br J Ophthalmol. 2017;101:56–61.PubMed
29.
Zurück zum Zitat Yun C, Huh J, Ahn SM, Lee B, Kim JT, Hwang SY, et al. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:57–70. Yun C, Huh J, Ahn SM, Lee B, Kim JT, Hwang SY, et al. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:57–70.
30.
Zurück zum Zitat Rochepeau C, Kodjikian L, Garcia M-AA, Mathis T. Optical coherence tomography angiography quantitative assessment of choriocapillaris blood flow in central serous chorioretinopathy. Am J Ophthalmol. 2018;194:26–34.PubMed Rochepeau C, Kodjikian L, Garcia M-AA, Mathis T. Optical coherence tomography angiography quantitative assessment of choriocapillaris blood flow in central serous chorioretinopathy. Am J Ophthalmol. 2018;194:26–34.PubMed
31.
Zurück zum Zitat Gal-Or O, Dansingani KK, Sebrow D, Dolz-Marco R, Freund KB. Inner choroidal flow signal attenuation in pachychoroid disease : optical coherence tomography angiography. Retina. 2018;38:1984–92.PubMed Gal-Or O, Dansingani KK, Sebrow D, Dolz-Marco R, Freund KB. Inner choroidal flow signal attenuation in pachychoroid disease : optical coherence tomography angiography. Retina. 2018;38:1984–92.PubMed
33.
Zurück zum Zitat Baek J, Kook L, Lee WK. Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid. Sci Rep. 2019;9:5565.PubMedPubMedCentral Baek J, Kook L, Lee WK. Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid. Sci Rep. 2019;9:5565.PubMedPubMedCentral
35.
Zurück zum Zitat Nichole J, Mitchell P, Younan C, Burlutsky G, Cheng C, Cheung CMG, et al. Ethnic variation in early age-related macular degeneration lesions between white Australians and Singaporean asians. Investig Ophthalmol Vis Sci. 2014;55:4421–9. Nichole J, Mitchell P, Younan C, Burlutsky G, Cheng C, Cheung CMG, et al. Ethnic variation in early age-related macular degeneration lesions between white Australians and Singaporean asians. Investig Ophthalmol Vis Sci. 2014;55:4421–9.
36.
Zurück zum Zitat Lee J, Kim M, Lee CS, Kim SS, Koh HJ, Lee SC, et al. Drusen subtypes and choroidal characteristics in asian eyes with typical neovascular age-related macular degeneration. Retina. 2020;40:490–8.PubMed Lee J, Kim M, Lee CS, Kim SS, Koh HJ, Lee SC, et al. Drusen subtypes and choroidal characteristics in asian eyes with typical neovascular age-related macular degeneration. Retina. 2020;40:490–8.PubMed
37.
Zurück zum Zitat Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study. Retina. 2019;39:670–8.PubMed Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study. Retina. 2019;39:670–8.PubMed
38.
Zurück zum Zitat Matsumoto H, Mukai R, Morimoto M, Tokui S, Kishi S, Akiyama H. Clinical characteristics of pachydrusen in central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:1127–32. Matsumoto H, Mukai R, Morimoto M, Tokui S, Kishi S, Akiyama H. Clinical characteristics of pachydrusen in central serous chorioretinopathy. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:1127–32.
39.
Zurück zum Zitat Baek J, Lee JH, Chung B, Lee K, Lee WK. Choroidal morphology under pachydrusen. Clin Exp Ophthalmol. 2019;47:498–504.PubMed Baek J, Lee JH, Chung B, Lee K, Lee WK. Choroidal morphology under pachydrusen. Clin Exp Ophthalmol. 2019;47:498–504.PubMed
40.
Zurück zum Zitat Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina. 2018;38:708–16.PubMed Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina. 2018;38:708–16.PubMed
41.
Zurück zum Zitat Cheung CMG, Gan A, Yanagi Y, Wong TY, Spaide R. Association between choroidal thickness and drusen subtypes in age-related macular degeneration. Ophthalmol Retina. 2018;2:1196–205.PubMed Cheung CMG, Gan A, Yanagi Y, Wong TY, Spaide R. Association between choroidal thickness and drusen subtypes in age-related macular degeneration. Ophthalmol Retina. 2018;2:1196–205.PubMed
42.
Zurück zum Zitat Singh S, Chakurkar R, Goud A, Rasheed M, Vupparaboina K, Chhablani J. Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort. Indian J Ophthalmol. 2019;67:1121–6.PubMedPubMedCentral Singh S, Chakurkar R, Goud A, Rasheed M, Vupparaboina K, Chhablani J. Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort. Indian J Ophthalmol. 2019;67:1121–6.PubMedPubMedCentral
43.
Zurück zum Zitat Singh SR, Oli A, Mohan S, Goud A, Rasheed MA, Vupparaboina KK, et al. Pachydrusen in Indian population: a hospital-based study. Indian J Ophthalmol. 2019;67:371–5.PubMedPubMedCentral Singh SR, Oli A, Mohan S, Goud A, Rasheed MA, Vupparaboina KK, et al. Pachydrusen in Indian population: a hospital-based study. Indian J Ophthalmol. 2019;67:371–5.PubMedPubMedCentral
44.
Zurück zum Zitat Fukuda Y, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, et al. Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration. Sci Rep. 2019;9:11906.PubMedPubMedCentral Fukuda Y, Sakurada Y, Yoneyama S, Kikushima W, Sugiyama A, Matsubara M, et al. Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration. Sci Rep. 2019;9:11906.PubMedPubMedCentral
45.
Zurück zum Zitat Lee J, Choi S, Lee CS, Kim M, Kim SS, Koh HJ, et al. Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types. Am J Ophthalmol. 2019;208:103–10.PubMed Lee J, Choi S, Lee CS, Kim M, Kim SS, Koh HJ, et al. Neovascularization in fellow eye of unilateral neovascular age-related macular degeneration according to different drusen types. Am J Ophthalmol. 2019;208:103–10.PubMed
46.
Zurück zum Zitat Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Indocyanine green angiography of pachychoroid pigment epitheliopathy. Retina. 2018;38:1668–74.PubMed Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Indocyanine green angiography of pachychoroid pigment epitheliopathy. Retina. 2018;38:1668–74.PubMed
47.
Zurück zum Zitat Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I. Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy. Br J Ophthalmol. 2017;102:473–8.PubMed Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I. Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy. Br J Ophthalmol. 2017;102:473–8.PubMed
48.
Zurück zum Zitat Karacorlu M, Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I. Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:2319–26. Karacorlu M, Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I. Long-term follow-up of pachychoroid pigment epitheliopathy and lesion characteristics. Graefe’s Arch Clin Exp Ophthalmol. 2018;256:2319–26.
49.
Zurück zum Zitat Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I. Outer nuclear layer thinning in pachychoroid pigment epitheliopathy. Retina. 2018;38:957–61.PubMed Ersoz MG, Karacorlu M, Arf S, Hocaoglu M, Sayman Muslubas I. Outer nuclear layer thinning in pachychoroid pigment epitheliopathy. Retina. 2018;38:957–61.PubMed
50.
Zurück zum Zitat Lee JH, Kim JY, Jung BJ, Lee WK. Focal disruptions in ellipsoid zone and interdigitation zone on spectral-domain optical coherence tomography in pachychoroid pigment epitheliopathy. Retina. 2019;39:1562–70.PubMed Lee JH, Kim JY, Jung BJ, Lee WK. Focal disruptions in ellipsoid zone and interdigitation zone on spectral-domain optical coherence tomography in pachychoroid pigment epitheliopathy. Retina. 2019;39:1562–70.PubMed
51.
Zurück zum Zitat Takahashi A, Ooto S, Yamashiro K, Tamura H, Oishi A, Miyata M, et al. Pachychoroid geographic atrophy. Ophthalmol Retina. 2018;2:295–305.PubMed Takahashi A, Ooto S, Yamashiro K, Tamura H, Oishi A, Miyata M, et al. Pachychoroid geographic atrophy. Ophthalmol Retina. 2018;2:295–305.PubMed
52.
Zurück zum Zitat Yanagi Y, Mohla A, Lee WK, Lee SY, Mathur R, Chan CM, et al. Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Investig Opthalmology Vis Sci. 2017;58:3488–95. Yanagi Y, Mohla A, Lee WK, Lee SY, Mathur R, Chan CM, et al. Prevalence and risk factors for nonexudative neovascularization in fellow eyes of patients with unilateral age-related macular degeneration and polypoidal choroidal vasculopathy. Investig Opthalmology Vis Sci. 2017;58:3488–95.
54.
Zurück zum Zitat Baek J, Lee JH, Lee WK. Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:1863–71. Baek J, Lee JH, Lee WK. Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:1863–71.
55.
Zurück zum Zitat Hariri A, Heussen FM, Nittala MG, Sadda SVR. Optical coherence tomographic correlates of angiographic subtypes of occult choroidal neovascularization. Investig Ophthalmol Vis Sci. 2013;54:8020–6. Hariri A, Heussen FM, Nittala MG, Sadda SVR. Optical coherence tomographic correlates of angiographic subtypes of occult choroidal neovascularization. Investig Ophthalmol Vis Sci. 2013;54:8020–6.
56.
Zurück zum Zitat Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina. 2007;27:589–94.PubMed Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina. 2007;27:589–94.PubMed
57.
Zurück zum Zitat Sheth J, Anantharaman G, Chandra S, Sivaprasad S. “Double-layer sign” on spectral domain optical coherence tomography in pachychoroid spectrum disease. Indian J Ophthalmol. 2018;66:1796–801.PubMedPubMedCentral Sheth J, Anantharaman G, Chandra S, Sivaprasad S. “Double-layer sign” on spectral domain optical coherence tomography in pachychoroid spectrum disease. Indian J Ophthalmol. 2018;66:1796–801.PubMedPubMedCentral
58.
Zurück zum Zitat Pichi F, Morara M, Veronese C, Ciardella AP. The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography. Int Ophthalmol. 2018;38:975–83.PubMed Pichi F, Morara M, Veronese C, Ciardella AP. The overlapping spectrum of flat irregular pigment epithelial detachment investigated by optical coherence tomography angiography. Int Ophthalmol. 2018;38:975–83.PubMed
60.
Zurück zum Zitat Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol. 2015;160:1243–54.e2. Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol. 2015;160:1243–54.e2.
61.
Zurück zum Zitat Carnevali A, Capuano V, Sacconi R, Querques L, Marchese A, Rabiolo A, et al. OCT angiography of treatment-naïve quiescent choroidal neovascularization in pachychoroid neovasculopathy. Ophthalmol Retina. 2017;1:328–32.PubMed Carnevali A, Capuano V, Sacconi R, Querques L, Marchese A, Rabiolo A, et al. OCT angiography of treatment-naïve quiescent choroidal neovascularization in pachychoroid neovasculopathy. Ophthalmol Retina. 2017;1:328–32.PubMed
63.
Zurück zum Zitat Terao N, Koizumi H, Kojima K, Yamagishi T, Nagata K, Kitazawa K, et al. Association of upregulated angiogenic cytokines with choroidal abnormalities in chronic central serous chorioretinopathy. Investig Opthalmol Vis Sci. 2018;59:5924–31. Terao N, Koizumi H, Kojima K, Yamagishi T, Nagata K, Kitazawa K, et al. Association of upregulated angiogenic cytokines with choroidal abnormalities in chronic central serous chorioretinopathy. Investig Opthalmol Vis Sci. 2018;59:5924–31.
64.
Zurück zum Zitat Hata M, Yamashiro K, Ooto S, Oishi A, Tamura H, Miyata M, et al. Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Investig Ophthalmol Vis Sci. 2017;58:292–8. Hata M, Yamashiro K, Ooto S, Oishi A, Tamura H, Miyata M, et al. Intraocular vascular endothelial growth factor levels in pachychoroid neovasculopathy and neovascular age-related macular degeneration. Investig Ophthalmol Vis Sci. 2017;58:292–8.
65.
Zurück zum Zitat Terao N, Koizumi H, Kojima K, Yamagishi T, Yamamoto Y, Yoshii K, et al. Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration. Sci Rep. 2018;8:10520.PubMedPubMedCentral Terao N, Koizumi H, Kojima K, Yamagishi T, Yamamoto Y, Yoshii K, et al. Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration. Sci Rep. 2018;8:10520.PubMedPubMedCentral
66.
Zurück zum Zitat Azuma K, Tan X, Asano S, Shimizu K, Ogawa A, Inoue T, et al. The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy. PLoS One. 2019;14:e0212055.PubMedPubMedCentral Azuma K, Tan X, Asano S, Shimizu K, Ogawa A, Inoue T, et al. The association of choroidal structure and its response to anti-VEGF treatment with the short-time outcome in pachychoroid neovasculopathy. PLoS One. 2019;14:e0212055.PubMedPubMedCentral
67.
Zurück zum Zitat Cho HJ, Jung SH, Cho S, Han JO, Park S, Kim JW. Intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy. J Ocul Pharmacol Ther. 2019;35:174–81.PubMed Cho HJ, Jung SH, Cho S, Han JO, Park S, Kim JW. Intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy. J Ocul Pharmacol Ther. 2019;35:174–81.PubMed
68.
Zurück zum Zitat Jung BJ, Kim JY, Lee JH, Baek J, Lee K, Lee WK. Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci Rep. 2019;9:2055.PubMedPubMedCentral Jung BJ, Kim JY, Lee JH, Baek J, Lee K, Lee WK. Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy. Sci Rep. 2019;9:2055.PubMedPubMedCentral
69.
Zurück zum Zitat Matsumoto H, Hiroe T, Morimoto M, Mimura K, Ito A, Akiyama H. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol. 2018;62:144–50.PubMed Matsumoto H, Hiroe T, Morimoto M, Mimura K, Ito A, Akiyama H. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration. Jpn J Ophthalmol. 2018;62:144–50.PubMed
70.
Zurück zum Zitat Roy R, Saurabh K, Shah D, Goel S. Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor. Indian J Ophthalmol. 2019;67:1678.PubMedPubMedCentral Roy R, Saurabh K, Shah D, Goel S. Treatment outcomes of pachychoroid neovasculopathy with photodynamic therapy and anti-vascular endothelial growth factor. Indian J Ophthalmol. 2019;67:1678.PubMedPubMedCentral
71.
Zurück zum Zitat Baek J, Lee JH, Jeon S, Lee WK. Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy. Eye. 2019;33:419–27.PubMed Baek J, Lee JH, Jeon S, Lee WK. Choroidal morphology and short-term outcomes of combination photodynamic therapy in polypoidal choroidal vasculopathy. Eye. 2019;33:419–27.PubMed
72.
Zurück zum Zitat Padrón-Pérez N, Arias L, Rubio M, Lorenzo D, García-Bru P, Català-Mora J, et al. Changes in choroidal thickness after intravitreal injection of anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Investig Ophthalmol Vis Sci. 2018;59:1119–24. Padrón-Pérez N, Arias L, Rubio M, Lorenzo D, García-Bru P, Català-Mora J, et al. Changes in choroidal thickness after intravitreal injection of anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Investig Ophthalmol Vis Sci. 2018;59:1119–24.
73.
Zurück zum Zitat Hara C, Wakabayashi T, Toyama H, Fukushima Y, Sayanagi K, Sato S, et al. Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept. Br J Ophthalmol. 2019;103:623–9. Hara C, Wakabayashi T, Toyama H, Fukushima Y, Sayanagi K, Sato S, et al. Characteristics of patients with neovascular age-related macular degeneration who are non-responders to intravitreal aflibercept. Br J Ophthalmol. 2019;103:623–9.
74.
Zurück zum Zitat Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal choroidal vasculopathy. Ophthalmology. 2018;125:708–24.PubMed Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal choroidal vasculopathy. Ophthalmology. 2018;125:708–24.PubMed
75.
Zurück zum Zitat Ueta T, Obata R, Inoue Y, Iriyama A, Takahashi H, Yamaguchi T, et al. Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology. 2009;116:2400–6.PubMed Ueta T, Obata R, Inoue Y, Iriyama A, Takahashi H, Yamaguchi T, et al. Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology. 2009;116:2400–6.PubMed
76.
Zurück zum Zitat Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R, et al. Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol. 2008;146:96–101.e2. Ueta T, Iriyama A, Francis J, Takahashi H, Adachi T, Obata R, et al. Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol. 2008;146:96–101.e2.
77.
Zurück zum Zitat Chung H, Byeon SH, Freund KB. Focal choroidal excavation and its association with pachychoroid spectrum disorders. Retina. 2017;37:199–221.PubMed Chung H, Byeon SH, Freund KB. Focal choroidal excavation and its association with pachychoroid spectrum disorders. Retina. 2017;37:199–221.PubMed
78.
Zurück zum Zitat Lee JH, Park H-YL, Baek J, Lee WK. Alterations of the lamina cribrosa are associated with peripapillary retinoschisis in glaucoma and pachychoroid spectrum disease. Ophthalmology. 2016;123:2066–76.PubMed Lee JH, Park H-YL, Baek J, Lee WK. Alterations of the lamina cribrosa are associated with peripapillary retinoschisis in glaucoma and pachychoroid spectrum disease. Ophthalmology. 2016;123:2066–76.PubMed
79.
Zurück zum Zitat Phasukkijwatana N, Freund KB, Dolz-Marco R, Al-Sheikh M, Keane PA, Egan CA, et al. Peripapillary pachychoroid syndrome. Retina. 2018;38:1652–67.PubMed Phasukkijwatana N, Freund KB, Dolz-Marco R, Al-Sheikh M, Keane PA, Egan CA, et al. Peripapillary pachychoroid syndrome. Retina. 2018;38:1652–67.PubMed
80.
Zurück zum Zitat Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye. 2019;33:14–33.PubMed Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye. 2019;33:14–33.PubMed
81.
Zurück zum Zitat Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367–74.PubMed Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39:367–74.PubMed
82.
Zurück zum Zitat Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844–51.PubMed Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844–51.PubMed
83.
Zurück zum Zitat Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15–22.e2. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15–22.e2.
84.
Zurück zum Zitat Yoshimura N. Age-related Macular Degeneration in the Japanese. Nihon Ganka Gakkai Zasshi. 2016;120:163–88 (discussion 189, in Japanese).PubMed Yoshimura N. Age-related Macular Degeneration in the Japanese. Nihon Ganka Gakkai Zasshi. 2016;120:163–88 (discussion 189, in Japanese).PubMed
85.
Zurück zum Zitat Takahashi K, Ishibashi T, Ogur Y, Yuzawa M. Classification and diagnostic criteria of age-related macular degeneration. Nihon Ganka Gakkai Zasshi. 2008;112:1076–84 (in Japanese).PubMed Takahashi K, Ishibashi T, Ogur Y, Yuzawa M. Classification and diagnostic criteria of age-related macular degeneration. Nihon Ganka Gakkai Zasshi. 2008;112:1076–84 (in Japanese).PubMed
86.
Zurück zum Zitat Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2015;99:624–8.PubMedPubMedCentral Tan CS, Ngo WK, Chen JP, Tan NW, Lim TH. EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2015;99:624–8.PubMedPubMedCentral
87.
Zurück zum Zitat Yannuzzi LA, Negrão S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.PubMed Yannuzzi LA, Negrão S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21:416–34.PubMed
88.
Zurück zum Zitat Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina. 2008;28:201–11.PubMed Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D, et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina. 2008;28:201–11.PubMed
89.
Zurück zum Zitat Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res. 2016;53:107–39.PubMed Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, et al. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res. 2016;53:107–39.PubMed
90.
Zurück zum Zitat Hageman G. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–32.PubMed Hageman G. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–32.PubMed
91.
Zurück zum Zitat Yanagi Y, Foo VHX, Yoshida A. Asian age-related macular degeneration: from basic science research perspective. Eye. 2019;33:34–49.PubMed Yanagi Y, Foo VHX, Yoshida A. Asian age-related macular degeneration: from basic science research perspective. Eye. 2019;33:34–49.PubMed
93.
Zurück zum Zitat Tanaka K, Mori R, Kawamura A, Nakashizuka H, Wakatsuki Y, Yuzawa M. Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2017;101:51–5.PubMed Tanaka K, Mori R, Kawamura A, Nakashizuka H, Wakatsuki Y, Yuzawa M. Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy. Br J Ophthalmol. 2017;101:51–5.PubMed
94.
Zurück zum Zitat Coscas G, Lupidi M, Coscas F, Benjelloun F, Zerbib J, Dirani A, et al. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Investig Ophthalmol Vis Sci. 2015;56:3187–95. Coscas G, Lupidi M, Coscas F, Benjelloun F, Zerbib J, Dirani A, et al. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration. Investig Ophthalmol Vis Sci. 2015;56:3187–95.
95.
Zurück zum Zitat Jang JW, Kim JM, Kang SW, Kim SJ, Bae K, Kim KT. Typical polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina. 2019;39:1995–2003.PubMed Jang JW, Kim JM, Kang SW, Kim SJ, Bae K, Kim KT. Typical polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina. 2019;39:1995–2003.PubMed
96.
Zurück zum Zitat Hata M, Tagawa M, Oishi A, Kawashima Y, Nakata I, Akagi-Kurashige Y, et al. Efficacy of photodynamic therapy for polypoidal choroidal vasculopathy associated with and without pachychoroid phenotypes. Ophthalmol Retina. 2019;3:1016–25.PubMed Hata M, Tagawa M, Oishi A, Kawashima Y, Nakata I, Akagi-Kurashige Y, et al. Efficacy of photodynamic therapy for polypoidal choroidal vasculopathy associated with and without pachychoroid phenotypes. Ophthalmol Retina. 2019;3:1016–25.PubMed
97.
Zurück zum Zitat Lee WK, Baek J, Dansingani KK, Lee JH, Freund KB. Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness. Retina. 2016;36:S73–82.PubMed Lee WK, Baek J, Dansingani KK, Lee JH, Freund KB. Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness. Retina. 2016;36:S73–82.PubMed
98.
Zurück zum Zitat Hosoda Y, Yoshikawa M, Miyake M, Tabara Y, Ahn J, Woo SJ, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci. 2018;115:6261–6.PubMed Hosoda Y, Yoshikawa M, Miyake M, Tabara Y, Ahn J, Woo SJ, et al. CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy. Proc Natl Acad Sci. 2018;115:6261–6.PubMed
99.
Zurück zum Zitat Lehmann M, Bousquet E, Beydoun T, Behar-Cohen F. Pachychoroid. Retina. 2015;35:10–6.PubMed Lehmann M, Bousquet E, Beydoun T, Behar-Cohen F. Pachychoroid. Retina. 2015;35:10–6.PubMed
100.
Zurück zum Zitat Hosoda Y, Yamashiro K, Miyake M, Ooto S, Oishi A, Miyata M, et al. Predictive genes for the prognosis of central serous chorioretinopathy. Ophthalmol Retina. 2019;3:985–92.PubMed Hosoda Y, Yamashiro K, Miyake M, Ooto S, Oishi A, Miyata M, et al. Predictive genes for the prognosis of central serous chorioretinopathy. Ophthalmol Retina. 2019;3:985–92.PubMed
Metadaten
Titel
Pachychoroid disease: a new perspective on exudative maculopathy
verfasst von
Yasuo Yanagi
Publikationsdatum
21.04.2020
Verlag
Springer Japan
Erschienen in
Japanese Journal of Ophthalmology / Ausgabe 4/2020
Print ISSN: 0021-5155
Elektronische ISSN: 1613-2246
DOI
https://doi.org/10.1007/s10384-020-00740-5

Weitere Artikel der Ausgabe 4/2020

Japanese Journal of Ophthalmology 4/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.